- Home
- OPTX vs VYNE Comparison
OPTX vs VYNE Comparison
Compare OPTX & VYNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPTX
- VYNE
- Stock Information
- Founded
- OPTX 1981
- VYNE 2003
- Country
- OPTX United States
- VYNE United States
- Employees
- OPTX N/A
- VYNE N/A
- Industry
- OPTX Blank Checks
- VYNE Biotechnology: Pharmaceutical Preparations
- Sector
- OPTX Finance
- VYNE Health Care
- Exchange
- OPTX Nasdaq
- VYNE Nasdaq
- Market Cap
- OPTX 40.4M
- VYNE 35.7M
- IPO Year
- OPTX N/A
- VYNE 2018
- Fundamental
- Price
- OPTX $1.43
- VYNE $1.84
- Analyst Decision
- OPTX
- VYNE Strong Buy
- Analyst Count
- OPTX 0
- VYNE 2
- Target Price
- OPTX N/A
- VYNE $6.88
- AVG Volume (30 Days)
- OPTX 146.1K
- VYNE 172.8K
- Earning Date
- OPTX 05-23-2025
- VYNE 05-08-2025
- Dividend Yield
- OPTX N/A
- VYNE N/A
- EPS Growth
- OPTX N/A
- VYNE N/A
- EPS
- OPTX 0.00
- VYNE N/A
- Revenue
- OPTX $29,392,186.00
- VYNE $501,000.00
- Revenue This Year
- OPTX N/A
- VYNE N/A
- Revenue Next Year
- OPTX N/A
- VYNE N/A
- P/E Ratio
- OPTX $858.98
- VYNE N/A
- Revenue Growth
- OPTX 4.36
- VYNE 18.16
- 52 Week Low
- OPTX $0.85
- VYNE $1.44
- 52 Week High
- OPTX $8.39
- VYNE $4.30
- Technical
- Relative Strength Index (RSI)
- OPTX 56.30
- VYNE 52.41
- Support Level
- OPTX $1.19
- VYNE $1.75
- Resistance Level
- OPTX $1.72
- VYNE $1.89
- Average True Range (ATR)
- OPTX 0.17
- VYNE 0.16
- MACD
- OPTX 0.04
- VYNE 0.06
- Stochastic Oscillator
- OPTX 58.57
- VYNE 74.07
About OPTX Syntec Optics Holdings Inc.
Syntec Optics Holdings Inc is vertically integrated from design and component manufacturing for lens system assembly to imaging module integration for system solutions. Making its tools, molding, and nano machining allows close interaction and recut ability, enabling special techniques to hold tolerances to sub-micron levels. It has steadily developed a variety of other complementary manufacturing techniques to provide a wide suite of horizontal capabilities including thin film deposition coatings, glass molding, polymer molding, tool-making, mechanical manufacturing, and nano machining.
About VYNE VYNE Therapeutics Inc.
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.